APIM THERAPEUTICS IS A BIOTECHNOLOGY COMPANY DEDICATED TO THE DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS TARGETING DNA REPAIR AND CELL CYCLE CONTROL

At APIM THERAPEUTICS AS we focus on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. Our approach is based on targeting PCNA, a “hub” protein regulating cell responses to pathological (cancer) and pharmacological (chemotherapy) stress. Through development of innovative peptide drugs which contain a novel PCNA-interacting Stress Switch Peptide Motif termed APIM, the company offers a unique physiological intervention point allowing cancer-specific tumor cell elimination.